Bruderman Asset Management LLC acquired a new position in shares of Stryker Corporation (NYSE:SYK) in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor acquired 1,083 shares of the medical technology company’s stock, valued at approximately $150,000.

Other hedge funds have also made changes to their positions in the company. Bollard Group LLC lifted its position in shares of Stryker Corporation by 0.4% during the 2nd quarter. Bollard Group LLC now owns 832 shares of the medical technology company’s stock worth $115,000 after buying an additional 3 shares during the last quarter. Motco lifted its position in shares of Stryker Corporation by 50.7% during the 2nd quarter. Motco now owns 826 shares of the medical technology company’s stock worth $115,000 after buying an additional 278 shares during the last quarter. James Investment Research Inc. bought a new stake in shares of Stryker Corporation during the 2nd quarter worth $155,000. Guardian Life Insurance Co. of America lifted its position in shares of Stryker Corporation by 0.8% during the 1st quarter. Guardian Life Insurance Co. of America now owns 1,199 shares of the medical technology company’s stock worth $158,000 after buying an additional 9 shares during the last quarter. Finally, Assetmark Inc. lifted its position in shares of Stryker Corporation by 0.3% during the 1st quarter. Assetmark Inc. now owns 1,274 shares of the medical technology company’s stock worth $168,000 after buying an additional 4 shares during the last quarter. Institutional investors and hedge funds own 74.13% of the company’s stock.

Stryker Corporation (SYK) opened at 149.00 on Friday. The stock’s 50 day moving average price is $142.44 and its 200-day moving average price is $139.99. Stryker Corporation has a 12 month low of $106.48 and a 12 month high of $149.23. The company has a market capitalization of $55.74 billion, a P/E ratio of 33.26 and a beta of 0.80.

Stryker Corporation (NYSE:SYK) last released its earnings results on Thursday, July 27th. The medical technology company reported $1.53 earnings per share for the quarter, beating analysts’ consensus estimates of $1.51 by $0.02. Stryker Corporation had a return on equity of 24.26% and a net margin of 14.22%. The company had revenue of $3.01 billion during the quarter, compared to analyst estimates of $2.98 billion. During the same quarter in the previous year, the company posted $1.39 EPS. Stryker Corporation’s revenue for the quarter was up 6.1% on a year-over-year basis. On average, equities research analysts predict that Stryker Corporation will post $6.46 EPS for the current fiscal year.

The business also recently announced a quarterly dividend, which will be paid on Tuesday, October 31st. Stockholders of record on Friday, September 29th will be paid a $0.425 dividend. This represents a $1.70 dividend on an annualized basis and a dividend yield of 1.14%. The ex-dividend date is Thursday, September 28th. Stryker Corporation’s dividend payout ratio (DPR) is presently 37.95%.

COPYRIGHT VIOLATION WARNING: “Bruderman Asset Management LLC Takes Position in Stryker Corporation (SYK)” was reported by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this piece of content on another site, it was stolen and reposted in violation of United States & international trademark and copyright laws. The original version of this piece of content can be read at https://www.thecerbatgem.com/2017/10/08/bruderman-asset-management-llc-takes-position-in-stryker-corporation-syk.html.

In other news, insider Graham A. Mclean sold 1,124 shares of the business’s stock in a transaction dated Tuesday, August 8th. The stock was sold at an average price of $146.26, for a total value of $164,396.24. Following the completion of the sale, the insider now owns 8,983 shares of the company’s stock, valued at approximately $1,313,853.58. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, insider David Floyd sold 19,305 shares of the business’s stock in a transaction dated Wednesday, July 12th. The shares were sold at an average price of $144.56, for a total value of $2,790,730.80. The disclosure for this sale can be found here. In the last three months, insiders sold 25,429 shares of company stock valued at $3,686,927. 7.40% of the stock is currently owned by corporate insiders.

Several analysts recently weighed in on the company. Cowen and Company set a $160.00 price objective on Stryker Corporation and gave the stock a “buy” rating in a research report on Friday. Zacks Investment Research downgraded Stryker Corporation from a “buy” rating to a “hold” rating in a research report on Thursday, August 17th. BidaskClub upgraded Stryker Corporation from a “hold” rating to a “buy” rating in a research report on Thursday, August 17th. Royal Bank Of Canada upped their price objective on Stryker Corporation from $140.00 to $155.00 and gave the stock an “outperform” rating in a research report on Friday, July 28th. Finally, Oppenheimer Holdings, Inc. set a $148.00 price objective on Stryker Corporation and gave the stock a “hold” rating in a research report on Friday, July 28th. Two investment analysts have rated the stock with a sell rating, nine have assigned a hold rating and twelve have assigned a buy rating to the company’s stock. The stock has a consensus rating of “Hold” and an average price target of $146.78.

Stryker Corporation Profile

Stryker Corporation is a medical technology company. The Company offers a range of medical technologies, including orthopedic, medical and surgical, and neurotechnology and spine products. The Company’s segments include Orthopaedics; MedSurg; Neurotechnology and Spine, and Corporate and Other. The Orthopaedics segment includes reconstructive (hip and knee) and trauma implant systems and other related products.

Want to see what other hedge funds are holding SYK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stryker Corporation (NYSE:SYK).

Institutional Ownership by Quarter for Stryker Corporation (NYSE:SYK)

Receive News & Stock Ratings for Stryker Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stryker Corporation and related stocks with our FREE daily email newsletter.